Edwards Lifesciences Corp (EW)

pos +0.00
Today's Range: 89.42 - 92.06 | EW Avg Daily Volume: 0
Last Update: 08/01/14 - 4:02 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $90.25
52 Week Range: $60.62 - $94.50
Oustanding Shares: 105,494,000
Market Cap: 9,702,283,200
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
EW Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for EW:
Revenue 0.00B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.71 $0.96 $3.30 $3.82
Number of Analysts 10 9 11 11
High Estimate $0.76 $1.03 $3.34 $4.02
Low Estimate $0.69 $0.90 $3.24 $3.68
Prior Year $0.68 $0.91 $3.13 $3.30
Growth Rate (Year over Year) 4.56% 5.98% 5.29% 15.78%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Jim Cramer

 | Jul 30, 2014 | 11:11 AM EDT

Where what the Fed does allegedly determines everything.


Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

bullishEdwards Lifesciences upgraded at JMP

Jun 11, 2014 | 7:57 AM EDT

EW was upgraded from Market Perform to Outperform, JMP Securities said. $97 price target. Estimates also increased, following positive physician surveys.


Jim Cramer

 | Jun 9, 2014 | 6:50 AM EDT

If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.


Paul Price

 | May 22, 2014 | 9:00 AM EDT

Keep a tally that summarizes all your related holdings: stock, calls and puts.


Chris Laudani

 | Apr 15, 2014 | 10:30 AM EDT

Sell into the pop as the good news is set.

bullishEdwards Lifesciences upgraded at JP Morgan

Apr 14, 2014 | 8:12 AM EDT

EW was upgraded from Underweight to Neutral, JP Morgan said. $78 price target. CoreValve injunction has materially altered the industry landscape.

bullishEdwards Lifesciences upgraded at Wells

Mar 10, 2014 | 8:09 AM EDT

EW was upgraded from Market Perform to Outperform, Wells Fargo said. FIM sales should help drive near-term growth. 


Paul Price

 | Jan 3, 2014 | 10:00 AM EST

Analyzing a pair of picks by Zacks.


Paul Price

 | Dec 11, 2013 | 8:30 AM EST

The company is a steady grower, but its stock has swooned.

Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
Last year saw the MC NYSE oscillator hit -300 on about five occasions, and each time a mas...
If you are in the NYC area, Bob Lang and I will be in town this Monday and Tuesday night. ...
There are no signals in IWM....Still watching zone 2 in WYNN for a potential entry. The up...


Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.